Home LiteratureArticle Details
PMID: 15274332 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors.

Anticancer research ·Vol. 24 ·No. 3a ·2004-00-00 ·Pages 1625-30

Liu Z, Klominek J

Abstract

Chemotaxis is defined as directional cell movement of cells towards concentration gradients of solubilized attractants, whereas chemokinesis is defined as random cell movement in the absence of chemoattractant gradients. Since tumor cell motility plays an important role in the process of tumor invasion and metastasis, we investigated these two distinct motile behaviors in highly invasive tumor, malignant mesothelioma. Chemotaxis and chemokinesis of mesothelioma cells were assayed using Boyden chambers fitted with filters coated with collagen type IV and different growth factors and cytokines were used as chemoattractants. We found that growth factors such as epidermal growth factor, transforming growth factor-alpha, amphiregulin, heparin-binding epidermal growth factor-like growth factor, beta-cellulin, insulin-like growth factor-I, insulin-like growth factor-II and stem cell factor stimulated directional (chemotactic) and/or random (chemokinetic) motility in all mesothelioma cell lines tested, whereas none of acidic fibroblast growth factor, basic fibroblast growth factor, granulocyte-macrophage colony-stimulating factor or interleukin-6 induced migration in the same mesothelioma cells. These findings provide evidence that: (i) multiple growth factors can induce chemotaxis and chemokinesis in malignant mesothelioma cell lines, and (ii) may contribute to our understanding of the highly invasive behavior of malignant mesotheliomas in vivo.

MeSH Terms
Cell Line, Tumor Cell Movement/drug effects Chemotactic Factors/pharmacology Chemotaxis/drug effects Cytokines/pharmacology Growth Substances/pharmacology Humans Mesothelioma/pathology
Chemicals
Chemotactic Factors Cytokines Growth Substances
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Liu Zhiwen
Department of Clinical Immunology, Karolinska Institute at Huddinge University Hospital, SE-141 86 Stockholm, Sweden.
Klominek Julius
Article Info
Journal
Anticancer research
Abbr.
Anticancer Res
ISSN
0250-7005
Published
2004-00-00
Pages
1625-30
Language
English
Region
Greece
NLM ID
8102988
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]